Glufast


Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 31.7%
Diabetes Mellitus 14.9%
Benign Prostatic Hyperplasia 9.9%
Constipation 8.9%
Hypertonic Bladder 8.9%
Hypertension 6.9%
Angina Pectoris 4.0%
Bronchitis 2.0%
Nausea 2.0%
Nervous System Disorder 2.0%
Prophylaxis 2.0%
Smoking Cessation Therapy 2.0%
Thyroid Function Test Abnormal 2.0%
Bladder Obstruction 1.0%
Hyperglycaemia 1.0%
Hyperparathyroidism 1.0%
Hepatic Function Abnormal 33.3%
Hypoglycaemia 11.1%
Loss Of Consciousness 7.4%
Road Traffic Accident 7.4%
Urine Output Decreased 7.4%
Altered State Of Consciousness 3.7%
Asthma 3.7%
Cholestasis 3.7%
Dyspnoea 3.7%
Gastrooesophageal Reflux Disease 3.7%
Hiatus Hernia 3.7%
Hyperammonaemia 3.7%
Hypoglycaemic Coma 3.7%
Toxic Epidermal Necrolysis 3.7%
Concomitant
Product Used For Unknown Indication 14.4%
Hypertension 14.0%
Diabetes Mellitus 13.3%
Prophylaxis 9.6%
Type 2 Diabetes Mellitus 9.0%
Hepatitis C 7.0%
Drug Use For Unknown Indication 4.3%
Rheumatoid Arthritis 4.1%
Chronic Hepatitis C 2.6%
Constipation 2.4%
Metastatic Renal Cell Carcinoma 2.4%
Gastritis 2.3%
Hyperlipidaemia 2.0%
Gastric Ulcer 1.9%
Myelodysplastic Syndrome 1.9%
Osteoporosis 1.9%
Cerebral Infarction 1.8%
Angina Pectoris 1.7%
Gastritis Prophylaxis 1.7%
Insomnia 1.7%
Interstitial Lung Disease 10.7%
Pyrexia 8.0%
Decreased Appetite 6.7%
Anaemia 6.0%
Hepatic Function Abnormal 6.0%
Rash 6.0%
Renal Impairment 6.0%
White Blood Cell Count Decreased 6.0%
Rhabdomyolysis 4.7%
Sepsis 4.7%
Death 4.0%
Hypotension 4.0%
Lipase Increased 4.0%
Cardiac Failure 3.3%
Diabetes Mellitus Inadequate Control 3.3%
Malignant Neoplasm Of Renal Pelvis 3.3%
Platelet Count Decreased 3.3%
Respiratory Failure 3.3%
Subdural Haematoma 3.3%
Transitional Cell Carcinoma 3.3%

Drug Data